AR029436A1 - Compuestos de eteres de dicarboxilato de calcio, metodos para su preparacion y su uso en tratamiento de las enfermedades vasculares y diabetes, composicion farmaceutica, formas cristalinas. - Google Patents

Compuestos de eteres de dicarboxilato de calcio, metodos para su preparacion y su uso en tratamiento de las enfermedades vasculares y diabetes, composicion farmaceutica, formas cristalinas.

Info

Publication number
AR029436A1
AR029436A1 ARP010100284A ARP010100284A AR029436A1 AR 029436 A1 AR029436 A1 AR 029436A1 AR P010100284 A ARP010100284 A AR P010100284A AR P010100284 A ARP010100284 A AR P010100284A AR 029436 A1 AR029436 A1 AR 029436A1
Authority
AR
Argentina
Prior art keywords
preparation
compounds
eteres
diabetes
treatment
Prior art date
Application number
ARP010100284A
Other languages
English (en)
Spanish (es)
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of AR029436A1 publication Critical patent/AR029436A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/125—Saturated compounds having only one carboxyl group and containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/305—Saturated compounds containing more than one carboxyl group containing ether groups, groups, groups, or groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
ARP010100284A 2000-01-25 2001-01-23 Compuestos de eteres de dicarboxilato de calcio, metodos para su preparacion y su uso en tratamiento de las enfermedades vasculares y diabetes, composicion farmaceutica, formas cristalinas. AR029436A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17782300P 2000-01-25 2000-01-25

Publications (1)

Publication Number Publication Date
AR029436A1 true AR029436A1 (es) 2003-06-25

Family

ID=22650106

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010100284A AR029436A1 (es) 2000-01-25 2001-01-23 Compuestos de eteres de dicarboxilato de calcio, metodos para su preparacion y su uso en tratamiento de las enfermedades vasculares y diabetes, composicion farmaceutica, formas cristalinas.

Country Status (39)

Country Link
EP (1) EP1259474B1 (cg-RX-API-DMAC10.html)
JP (1) JP4750995B2 (cg-RX-API-DMAC10.html)
KR (1) KR20020073182A (cg-RX-API-DMAC10.html)
CN (1) CN1395555A (cg-RX-API-DMAC10.html)
AP (1) AP2002002587A0 (cg-RX-API-DMAC10.html)
AR (1) AR029436A1 (cg-RX-API-DMAC10.html)
AT (1) ATE431326T1 (cg-RX-API-DMAC10.html)
AU (1) AU2214001A (cg-RX-API-DMAC10.html)
BG (1) BG106851A (cg-RX-API-DMAC10.html)
BR (1) BR0107763A (cg-RX-API-DMAC10.html)
CA (1) CA2397960C (cg-RX-API-DMAC10.html)
CO (1) CO5261537A1 (cg-RX-API-DMAC10.html)
CZ (1) CZ20022474A3 (cg-RX-API-DMAC10.html)
DE (1) DE60138686D1 (cg-RX-API-DMAC10.html)
DK (1) DK1259474T3 (cg-RX-API-DMAC10.html)
DZ (1) DZ3239A1 (cg-RX-API-DMAC10.html)
EA (1) EA004862B1 (cg-RX-API-DMAC10.html)
EE (1) EE200200404A (cg-RX-API-DMAC10.html)
ES (1) ES2324281T3 (cg-RX-API-DMAC10.html)
GE (1) GEP20053428B (cg-RX-API-DMAC10.html)
GT (1) GT200100015A (cg-RX-API-DMAC10.html)
HN (1) HN2001000011A (cg-RX-API-DMAC10.html)
HU (1) HUP0204422A3 (cg-RX-API-DMAC10.html)
IL (1) IL150541A0 (cg-RX-API-DMAC10.html)
IS (1) IS6442A (cg-RX-API-DMAC10.html)
MA (1) MA26867A1 (cg-RX-API-DMAC10.html)
MX (1) MXPA02007223A (cg-RX-API-DMAC10.html)
NO (1) NO20023526L (cg-RX-API-DMAC10.html)
NZ (1) NZ519550A (cg-RX-API-DMAC10.html)
OA (1) OA12166A (cg-RX-API-DMAC10.html)
PA (1) PA8510601A1 (cg-RX-API-DMAC10.html)
PE (1) PE20011064A1 (cg-RX-API-DMAC10.html)
PL (1) PL357076A1 (cg-RX-API-DMAC10.html)
SK (1) SK10622002A3 (cg-RX-API-DMAC10.html)
SV (1) SV2002000290A (cg-RX-API-DMAC10.html)
TN (1) TNSN01013A1 (cg-RX-API-DMAC10.html)
UY (1) UY26550A1 (cg-RX-API-DMAC10.html)
WO (1) WO2001055078A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA200205880B (cg-RX-API-DMAC10.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1045691T1 (en) * 1997-12-12 2005-04-30 Warner-Lambert Company Llc Statin-carboxyalkylether combinations
JP2006501238A (ja) * 2002-08-22 2006-01-12 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー 骨関節炎を治療する方法
US7816405B2 (en) 2005-04-19 2010-10-19 Eisai R&D Management Co., Ltd. Calcium bis [(2S)-3-[3-[(2S)-3-(4-chloro-2-cyanophenoxy)-2-fluoropropoxy]phenyl ]-2-isopropoxypropionate] and intermediate thereof
JPWO2006115130A1 (ja) * 2005-04-19 2008-12-18 エーザイ・アール・アンド・ディー・マネジメント株式会社 ビス[(2s)−3−[3−[(2s)−3−(4−クロロ−2−シアノフェノキシ)−2−フルオロプロポキシ]フェニル]−2−イソプロポキシプロピオン酸]カルシウム及びその中間体
EP3218349A2 (en) * 2014-11-14 2017-09-20 Gemphire Therapeutics Inc. Processes and intermediates for preparing , -dicarboxylic acid-terminated dialkane ethers
EP3612171A4 (en) 2017-04-18 2020-10-21 Gemphire Therapeutics Inc. GEMCABENE, PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, COMPOSITIONS THEREOF AND PROCEDURES FOR THE USE OF THE SAME
JP2022505033A (ja) * 2018-10-18 2022-01-14 ジェムフィアー セラピューティクス インコーポレイテッド ゲムカベン、薬学的に許容されるその塩、その組成物、およびその使用方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648387A (en) 1995-03-24 1997-07-15 Warner-Lambert Company Carboxyalkylethers, formulations, and treatment of vascular diseases
NZ503982A (en) 1997-12-12 2002-03-28 Warner Lambert Co Statin-carboxyalkylether combinations useful for treating vascular disorders and diabetes mellitus

Also Published As

Publication number Publication date
BR0107763A (pt) 2002-11-12
MXPA02007223A (es) 2002-11-29
IS6442A (is) 2002-06-25
DK1259474T3 (da) 2009-07-20
EA004862B1 (ru) 2004-08-26
WO2001055078A1 (en) 2001-08-02
HUP0204422A2 (en) 2003-05-28
AP2002002587A0 (en) 2002-09-30
MA26867A1 (fr) 2004-12-20
KR20020073182A (ko) 2002-09-19
PA8510601A1 (es) 2002-08-26
NZ519550A (en) 2003-11-28
JP2003520835A (ja) 2003-07-08
ATE431326T1 (de) 2009-05-15
GEP20053428B (en) 2005-01-25
EP1259474A1 (en) 2002-11-27
JP4750995B2 (ja) 2011-08-17
TNSN01013A1 (fr) 2005-11-10
BG106851A (en) 2003-01-31
SV2002000290A (es) 2002-07-16
ES2324281T3 (es) 2009-08-04
CO5261537A1 (es) 2003-03-31
IL150541A0 (en) 2003-02-12
AU2214001A (en) 2001-08-07
NO20023526L (no) 2002-08-27
NO20023526D0 (no) 2002-07-24
PL357076A1 (en) 2004-07-12
CA2397960C (en) 2008-09-09
UY26550A1 (es) 2001-08-27
DZ3239A1 (fr) 2001-08-02
SK10622002A3 (sk) 2003-07-01
CZ20022474A3 (cs) 2003-06-18
DE60138686D1 (de) 2009-06-25
CN1395555A (zh) 2003-02-05
EP1259474B1 (en) 2009-05-13
HUP0204422A3 (en) 2003-08-28
CA2397960A1 (en) 2001-08-02
GT200100015A (es) 2001-10-19
EE200200404A (et) 2003-10-15
PE20011064A1 (es) 2001-10-22
ZA200205880B (en) 2003-07-23
OA12166A (en) 2003-11-07
EA200200641A1 (ru) 2002-12-26
HN2001000011A (es) 2001-06-13

Similar Documents

Publication Publication Date Title
ES2013067A6 (es) Un procedimiento para producir un derivado de piperazina.
PA8609201A1 (es) Piridinonas sustituidas
AR033499A1 (es) Derivado de quinazolina, proceso para su preparacion, composicion farmaceutica que lo comprende y su uso en la fabricacion de medicamentos para usar en la produccion de un efecto antiangeogenico y/o reductor de la permeabilidad vascular en un animal de sangre caliente
AR029383A1 (es) Moleculas pequenas, los intermediarios para su sintesis, las composiciones farmaceuticas que las contienen y su uso para preparar un medicamento destinado al tratamiento o la profilaxis de enfermedades inflamatorias o mediadas por celulas inmunes
ECSP034732A (es) Derivado de fenetanolamina para el tratamiento de enfermedades respiratorias
ATE411280T1 (de) Phenoxyessigsäure-derivate zur behandlung von störungen der atemwege
BR9916790A (pt) Uso de um composto, composto, processo para amanufatura do mesmo, composição farmacêtica, e,método para produzir um efeito de dano vascularem um animal de sangue quente
AR041932A1 (es) Derivados de ciclohexano espirociclicos, preparacion de los mismos, su uso en la fabricacion de medicamentos y dichos medicamentos.
DOP2006000084A (es) Compuestos sulfoximino-macrociclicos y sus sales, composiciones farmaceuticas que comprenden dichos compuestos, metodos de preparacion y usos de los mismos
AR031248A1 (es) Compuestos de ditosilato de quinazolina, composicion farmaceutica, metodo de tratamiento y uso en terapia y proceso para la preparacion de dichos compuestos
AR032136A1 (es) Compuestos espiroheterociclicos utiles como inhibidores reversibles de cisteina-proteasas
ES2017837A6 (es) Un procedimiento de preparacion de derivados de 4h-1-benzopiran-4-ona o sus sales.
AR003440A1 (es) Nuevos derivados de aminoacidos, formulacion farmaceutica que los contiene, uso de dichos derivados para preparar medicamentos y procedimiento para la preparacion de dichos derivados.
KR20070098947A (ko) 하이포할로우스 산과의 조합의 n-할로겐화 아미노산 및n,n-디할로겐화 아미노산
UY28343A1 (es) Derivados de 2-amino-piridina utiles para el tratamiento de enfermedades
UY26956A1 (es) Derivados del pirazol para el tratamiento de enfermedades virales
EP1373207A4 (en) NEW AMLODIPINCAMSYLATE AND METHOD FOR THE PRODUCTION THEREOF
EA200601846A1 (ru) Содержащие бензоксазины лекарственные комбинации для лечения заболеваний дыхательных путей
ATE427944T1 (de) Isoflavonderivative von tectoridin, deren herstellung und antivirale medikamente, die diese als wirksame bestandteile enthalten
MX9307363A (es) Compuestos de 2-nitroarilo y 2-cianoarilo y composiciones farmaceuticas que los contienen.
DE502005008971D1 (de) Substituierte 1,4,8-triazaspiroä4.5 decan-2-on-verbindungen zur behandlung von fettsucht
PA8525801A1 (es) Compuestos de pirazol, composiciones farmacéuticas, y métodos para modular y/o inhibir la actividad de erab/hadh2
WO2003004097A1 (es) Empleo de derivados de ácidos 2,5-dihidroxibencenosulfónicos en la elaboración de un medicamento para potenciar el efecto de otros fármacos en el tratamiento de la disfunción eréctil
PT1218401E (pt) 4-benzilaminoquinolinas conjugadas com acido biliar e seus heterociclicos metodos de sua producao medicamentos contendo estes compostos e sua aplicacao
UY26550A1 (es) Éteres de dicarboxilato de calcio, métodos para su preparación y tratamiento de las enfermedades vasculares y diabetes con los mismos.

Legal Events

Date Code Title Description
FB Suspension of granting procedure